Is QURE bullish or bearish?

Buzzberg tracks 11 bullish ideas, 2 bearish ideas, 34 watch signals, 1 avoid signal for QURE from 14 authors across 14 sources. Historical directional balance: 19% (bullish minus bearish, divided by all idea records).

What are investors saying about uniQure N.V. (QURE)?

Buzzberg records opinions on uniQure N.V. (QURE) from 14 authors across 14 sources, including X/Twitter, YouTube, Reddit and Substack. Available history: 11 bullish ideas, 2 bearish ideas, 34 watch signals, 1 avoid signal. Historical directional balance: 19% (bullish minus bearish, divided by all idea records).

QURE uniQure N.V. Loading... : Investor Sentiment and Bull/Bear Views

Loading chart...

Top Calls

seedy19tron

QUREShort

+40.6%

Sep 29Entry39.5→Now23.46

QURE efficacy fades, Huntington's data deteriorates Open original source

A May MD

QURELong

+10.7%

Sep 29Entry21.2→Now23.46

Bought QURE mid-teens, sees approval path intact Open original source

Price change since each call, adjusted for long/short direction. Results calculated: Oct 02, 21:47

Feed

All posts Open calls Terminal View

Time Author Thesis Company / ticker Signal Since call Source

13:19
Sep 29

A May MD

Buy QURE; selloff misread key trial endpoints

Buy QURE after the selloff into the low teens: the market misread the lost statistical significance — the key 3-year cUHDRS accelerated-approval endpoint deepened with new patients, and the 4-year miss reflects a halved external control arm while TFC stayed significant.

QURE uniQure N.V. Long HOLD —

13:18
Sep 29

A May MD

Long QURE on intact approval endpoints

Stay long QURE: the 3-year cUHDRS effect deepened and the year-4 stat-sig miss stems from a halved external control arm while TFC stayed significant, so the selloff to the low teens misreads approval-relevant endpoints.

QURE uniQure N.V. Long HOLD —

13:05
Sep 29

A May MD

Bought QURE mid-teens, sees approval path intact

Discloses buying QURE in mid-teens after selloff, backing parent thesis that accelerated approval rests on better 3-year data and 4-year TFC significance, with FDA decision as catalyst.

QURE uniQure N.V. Long 2ND —

About QURE Investor Commentary

Across the available history and selected sources, Buzzberg tracks QURE (uniQure N.V.) across 14 sources: 11 bullish vs 2 bearish calls from 14 authors. Historical directional balance: 19% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 48 total trade ideas tracked. Past 7 days, before deduplication: 3 bullish, 1 bearish, 13 other directions. Latest voices: A May MD.

QU QURE uniQure N.V. Loading... : Investor Sentiment and Bull/Bear Views

About QURE Investor Commentary

QURE uniQure N.V. Loading... : Investor Sentiment and Bull/Bear Views